The Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). Research proposals must address one or more of our research priorities:
- To define the pathogenesis of cancers including head and neck and anogenital squamous cell carcinomas that affect persons with FA, and to develop strategies for early detection, prevention, treatment, and cure.
- To understand how alteration of the FA genes and their products lead to the clinical manifestations of the disease.
- To determine the causes of bone marrow failure, myelodysplasia, and leukemia in individuals with FA, and to develop strategies to prevent, treat and cure these disorders.
- To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
- To support the creation of shared resources, databases, and technologies for the international FA research community.
What Funding Opportunities are Available?
Investigators can apply for Research Grant Awards (RGA) which range from $25,000 - $250,000 for one- to two-year projects that address our research priorities. Projects may be pre-clinical or clinical in nature. Preliminary data is not required but is preferred. FARF seeks to fund innovative project ideas that have the potential to make significant impact on our understanding of the disease and clinical care for people with FA.
Am I Eligible To Apply?
Researchers who hold a PhD, MD, or equivalent degree from both US and international academic, nonprofit, or for-profit institutions are invited to apply. Researchers previously funded by FARF, or those new to the FA field, including assistant, associate, and full professors, are all encouraged to apply.